Inge Mertens

AI for tumour proportion scoring of programmed death‐ligand 1 immunohistochemistry in non‐small cell lung cancer: a review of commercial and non‐commercial tools

Programmed death‐ligand 1 (PD‐L1) expression, commonly quantified as tumour proportion score (TPS), is a key biomarker guiding immunotherapy in non‐small cell lung cancer (NSCLC). Manual scoring of PD‐L1 immunohistochemistry (IHC) is time‐consuming and challenged by preanalytical...